Q1 2014

Filed May 15, 2014 · 10-Q · 45 days after period end · 0001469709-14-000183

Q1 2014 · 10-Q

Revenue

$17.76K

— vs Q1 2013

Net Income

-$628.52K

N/M vs Q1 2013

EPS Diluted

-$0.01

N/M vs Q1 2013

Gross Profit$9,311—

Operating Income

Same quarter

Metric	Q1 2014	Q1 2013	Q1 2012	Q1 2011
Revenue	$17.76K	$0.00	$1.67K	$0.00
Net Income	-$628.52K	-$1.13M	-$430.78K	$0.00
EPS Diluted	-$0.01	-$0.02	-$0.01	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Endonovo Therapeutics, Inc. · CIK 1528172 · Engraved from SEC EDGAR